Which Is Better: Clinical Research and Precision Medicine Agents? When AI Learns to “Do Research”
In the era of precision medicine, an awkward mismatch persists: data is exploding while insight is scarce. The cost of genome sequencing has dropped to the thousand-yuan level, electronic health records hold decades of patient trajectories, and public cancer dependency maps cover over a thousand cell lines—yet for most clinical researchers, these resources remain “visible but out of reach.” Extracting cohorts requires writing SQL, training models requires tuning parameters, interpreting gene dependencies requires a bioinformatics background, and writing reports requires familiarity with all kinds of guidelines. Many researchers also search for what functions clinical research and precision medicine agents have and how to use clinical research Agents.
What if there were an agent that could connect these steps together?
A group of clinical research agent frameworks that have emerged recently is trying to answer this question. They are not wrappers around a single model; rather, they orchestrate “Skills” from multiple specialized domains into an interactive, iterative research pipeline. From signal processing to report writing, from cohort construction to treatment recommendations, agents are redefining the boundaries of clinical research.
Core Skills System
A complete clinical research agent needs to cover full-chain capabilities from raw data to clinical decisions. The following are six key skill modules:
1. Physiological Signal Processing: NeuroKit2
Data in clinical research goes far beyond structured laboratory values and diagnostic codes. ECG, EEG, electrodermal activity, respiratory signals, and EMG signals—these bioelectrical signals carry real-time information about autonomic nervous system, central nervous system activity, and muscle function, but the raw signals themselves are almost unreadable.
NeuroKit2 is currently the most mature Python toolbox for physiological signal processing, providing a complete pipeline from signal simulation and preprocessing to feature extraction. Its design philosophy is to “enable users without programming experience to run complete preprocessing and analysis routines.” For a clinical study that needs to include physiological indicators as outcome variables, the agent can automatically call NeuroKit2 to complete R-peak detection for ECG, time-frequency domain analysis of HRV, and phase component decomposition of EDA, outputting quantitative features that can directly enter statistical models.
2. Clinical Decision Support: Precision Cohort Analysis
Traditional clinical decision support systems output guideline recommendations based on population-average effects. But for a 68-year-old patient with type 2 diabetes, HbA1c 7.8%, and comorbid chronic kidney disease, is the metformin recommended by guidelines really the optimal choice? The answer depends on what actually happened to “patients similar to him” after receiving different treatments.
Precision Cohort analysis offers a different path: extract from the EHR a group of historical patients whose clinical characteristics are most similar to the current patient, and retrospectively compare the outcome differences brought by different treatment choices at the same decision point. A study in the Netherlands applied this method to primary care data from 11,490 patients with type 2 diabetes, validating technical feasibility while also exposing the constraints of data scale on statistical power. The value of the agent lies in its ability to automate the entire process from decision point identification and similarity modeling to cohort generation, translating methodological feasibility into operational feasibility.
3. Cancer Dependency Map: DepMap Query
In oncology research, “can this gene serve as a drug target” is a high-frequency question. Through genome-wide CRISPR screening, the DepMap project systematically knocks out each gene in more than 1,000 cancer cell lines, measures the impact on cell survival, and thereby draws a “cancer dependency map.”
For an agent, DepMap querying is an orchestration-ready analysis task. Given a driver mutation (for example, STAG2-deficient Ewing sarcoma), the agent can retrieve co-dependency genes, assess selectivity, and identify druggable targets. In a real case, researchers discovered HDAC8 as a synthetic lethal target for STAG2-mutant Ewing sarcoma precisely through DepMap co-dependency analysis. This “from gene to target” retrieval and assessment process is exactly the step that agents can significantly accelerate.
4. Medical Deep Learning: PyHealth Pipeline
Electronic health record data is structured, but also heterogeneous, sparse, and irregularly time-series. Modeling such data with traditional statistical methods is often inadequate, while the engineering barrier to building deep learning pipelines from scratch is too high.
The goal of PyHealth 2.0 is to enable clinical AI research to “complete predictive modeling within 7 lines of code.” It unifies more than 15 datasets, more than 20 clinical tasks (including sleep staging, medication recommendation, readmission prediction, etc.), and more than 25 models, while through a streaming design reducing memory usage to a level that can run on a 16GB laptop. For an agent, PyHealth provides a standardized “data→task→model→training→evaluation” interface, enabling the agent to automatically select appropriate datasets and model architectures according to the research question.
5. Report Writing: Clinical Reporting Standards
The output of clinical research ultimately has to land in documents. Case reports, imaging diagnostic reports, pathology reports, and clinical trial reports—each type has strict formatting standards and content requirements. A standardized pathology report needs to include gross description, microscopic description, diagnosis, staging, and margin status; oncology cases also need to follow CAP's synoptic reporting template. Clinical trial reports need to fully describe the design scheme, inclusion and exclusion criteria, statistical methods, result analysis, and conclusions.
The agent's report-writing skill is essentially automation of “structured template + data filling.” But where it is smarter than a template is that it can select appropriate reporting standards according to the research type, extract key data from analysis results, and generate narrative text that conforms to professional standards.
6. Treatment Plan Generation
The “P” (Plan) part of a SOAP note carries the implementation of clinical decisions: specific interventions, referral recommendations, patient education points, and follow-up arrangements. In the context of precision medicine, treatment plan documents need to integrate genetic testing results, pharmacogenomic information, comorbidity status, and patient preferences.
The recently released dudu agent in China is precisely aimed at this scenario: relying on Chinese population genetic characteristic data and pharmacogenomic testing, it generates individualized medication plans, covering the closed loop from genetic testing to medication recommendations. The core challenge of such systems is not generating fluent text, but ensuring that the recommended drug-gene interaction relationships are evidence-based and can be quickly interpreted and verified by clinicians.
From Skills to System: Orchestration Logic
Viewed individually, each of these six skills is a tool that has been validated within its own domain. The value of the agent lies in orchestration—breaking down a vague research intent into an executable sequence of skill calls and providing reviewable intermediate products at each step.
A typical interaction flow might look like this:
- Step 1: Structuring the research question. The user inputs “I want to study the impact of sleep quality on glycemic control in patients with type 2 diabetes.” The agent needs to translate this broad question into an operational research design: target population, exposure variable, outcome variable, covariates, and inclusion/exclusion criteria.
- Step 2: Cohort construction. If using MIMIC-IV or OMOP-format EHR data, the agent automatically generates SQL queries, extracts the cohort of eligible patients, and outputs a data quality report.
- Step 3: Quantifying exposure and outcomes. Sleep quality may come from physiological signals from wearable devices (calling NeuroKit2 to process sleep staging features derived from PPG/ECG), while glycemic control comes from laboratory test values. The agent needs to handle time alignment and missing values across different data sources.
- Step 4: Analysis. For predictive modeling tasks, PyHealth provides an end-to-end pipeline; for treatment effect comparison, the precision cohort method generates individualized comparative evidence.
- Step 5: Report generation. According to the applicable reporting standards (STROBE for observational studies, TRIPOD+AI for prediction models), the agent organizes the analysis results into a structured document.
The key feature of the entire process is: humans have the power of review and correction at every node. The agent is not a black box; every intermediate product it generates—research protocol, SQL query, feature engineering steps, model evaluation metrics, report draft—is inspectable. Researchers can stop, modify, and rerun at any stage.
Current Status and Boundaries
Clinical research agents are still a young field. Existing frameworks have made impressive progress in technical feasibility, but there is still a considerable distance to go before they become “trustworthy clinical research partners.”
The core challenge is the lack of validation. A 2026 scoping review pointed out that evaluations of medical agents are mainly concentrated in simulated environments or laboratory conditions, diagnostic accuracy is mainly evaluated in “multimodal systems,” and “clinical outcomes and safety endpoints are rarely involved.” One study reported a diagnostic accuracy of 88.4%, but this only means that on a test set of 551 cases, the agent's diagnosis was consistent with some reference standard—it does not mean that the agent's recommendations would improve patient outcomes.
Another practical constraint is the tension between data scale and statistical power. Precision cohort analysis is technically feasible, but the Dutch study found that for many treatment decision points, the number of available historical patients is insufficient to produce statistically significant estimates of treatment effects. Agents can accelerate analysis, but they cannot create data out of thin air.
The ambiguity of responsibility attribution is a structural obstacle to clinical integration. When reports generated by an agent are incorporated into research records, and when the treatment plans it recommends are adopted by doctors, who bears responsibility for errors? The regulatory framework is still evolving, and most advanced platforms currently remain in a “for research use only” status.